Uzbekistan - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Uzbekistan Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases was down by 9% year on year. In 2019, the country was number 25 among other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 2,405 Cases. Uzbekistan is overtaken by Nigeria, which was ranked number 24 at 2,433 Cases and is followed by Nigeria at 2,384 Cases. India ranked the highest with 66,255 Cases in 2019, that is an increase of 13.6% compared to 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 2,405.00 |
| 2018 | 2,349.00 |
| 2017 | 2,265.00 |
| 2016 | 1,986.00 |
| 2015 | 2,149.00 |
How does Uzbekistan rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 24 |
#24
Nigeria
|
2,433 | 2019 | +7.3 % | +25.0 % | View data | |
| 25 |
#25
Uzbekistan
|
2,405 | 2019 | +2.4 % | -8.9 % | View data | |
| 27 |
#27
North Korea
|
2,354 | 2019 | +32.1 % | +64.2 % | View data | |